Всемирная организация здравоохранения (ВОЗ / WHO) · Journal articles

Cause-specific mortality rates in sub-Saharan Africa and Bangladesh.

Всемирная организация здравоохранения
Открыть оригинал документа

Полный текст размещён на сайте публикующей организации. lawenc.com индексирует метаданные и ведёт на официальный источник.

Полный текст

181Bulletin of the World Health Organization | March 2006, 84 (3)

Objective To provide internationally comparable data on the frequencies of different causes of death. Methods We analysed verbal autopsies obtained during 1999–2002 from 12 demographic surveillance sites in sub-Saharan Africa and Bangladesh to find cause-specific and age-specific mortality rates. The cause-of-death codes used by the sites were harmonized to conform to the ICD-10 system, and summarized with the classification system of the Global Burden of Disease 2000 (Version 2). Findings Causes of death in the African sites differ strongly from those in Bangladesh, where there is some evidence of a health transition from communicable to noncommunicable diseases, and little malaria. HIV dominates in causes of mortality in the South African sites, which contrast with those in highly malaria endemic sites elsewhere in sub-Saharan Africa (even in neighbouring Mozambique). The contributions of measles and diarrhoeal diseases to mortality in sub-Saharan Africa are lower than has been previously suggested, while malaria is of relatively greater importance. Conclusion The different patterns of mortality we identified may be a result of recent changes in the availability and effectiveness of health interventions against childhood cluster diseases.

Keywords Mortality/statistics; Cause of death; Statistics; Africa South of the Sahara; Bangladesh (source: MeSH, NLM). Mots clés Mortalités/statistique; Cause décès; Statistiques; Afrique subsaharienne; Bangladesh (source: MeSH, INSERM). Palabras clave Mortalidad/estadística; Causa de muerte; Estadística; África del Sur del Sahara; Bangladesh (fuente: DeCS, BIREME).

Bulletin of the World Health Organization 2006;84:181-188.

Voir page 187 le résumé en français. En la página 187 figura un resumen en español.

Introduction Statistics on causes of death are in great demand for developing and implementii ing public health interventions,1 but few parts of the world have estimates of causeispecific mortality rates that are reliable enough.2 This inadequacy is most common in developing countries, where medical personnel are rarely present to

a Navrongo Health Research Centre, Navrongo, Ghana. b Swiss Tropical Institute, Basel, Switzerland. c University of Washington, Washington, WA, USA. d London School of Hygiene and Tropical Medicine, London, England. e ACDIS, Africa Centre, University of KwaZulu-Natal, Durban, South Africa. f Agincourt DSS, Department of Public Health University of Witwatesrand, Johannesburg, South Africa. g Butajira DSS, Department of Community Health, Addis Ababa University, Addis Ababa, Ethiopia. h Health System and Infectious Disease Unit, ICDDR,B, Dhakar, Bangladesh. i Ifakara Health Research and Development Centre, Ifakara, United Republic of Tanzania. j Kisumu DSS, Centre for Disease Control and Prevention, Kenya Medical Research Centre, Kisuma, Kenya. k Manhica DSS, Centro de Investigaçâo em Saude de Manhiça, Maputo Province, Mozambique. l Matlab DSS, ICDDR, B, Dhakar, Bangladesh. n Niakhar DSS, Institut de Recherche et Développement, Niakhar, Senegal. o Nouna Health Research Centre, Kossi Province, Burkina Faso. p Rufiji DSS, Tanzania Essential Health Interventions Project, Rufiji, United Republic of Tanzania. q INDEPTH Network Secretariat, PO Box GP14550, Accra, Ghana. Correspondence to this author (fred.binka@indepth-network.org). Ref. No. 05-026492 (Submitted: 8 September 2005 – Final revised version received: 21 November 2005 – Accepted: 23 November 2005)

Cause-specific mortality rates in sub-Saharan Africa and Bangladesh Martin Adjuik,a Tom Smith,b Sam Clark,c Jim Todd,d Anu Garrib,e Yohannes Kinfu,f Kathy Kahn,g Mitiki Mola,h Ali Ashraf,i Honorati Masanja,j Ubaje Adazu,k Jahit Sacarlal,l Nurul Alam,m Adama Marra,n Adjima Gbangou,o Eleuther Mwageni,p & Fred Binka q

record details of deaths, and information on the causes of deaths is usually of poor quality.3 Because of the absence of reliii able information, the overall numbers of deaths and thus, the allicause mortality rates, are also highly uncertain.

An increasing number of areas in the developing world, especially in Africa, prospectively monitor demographic

events, and can thus provide accurate ageispecific mortality rates,4 often for populations of many tens of thousands of people. Many of these Demographic Surveillance Sites (DSS) use verbal autopsy (VA) to assign causes of death. This process involves interviewing famii ily members about the circumstances leading to death, and the symptoms and

Arabic

182 Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Measuring mortality in developing countries Martin Adjuik et al.

signs seen during the illness that preii ceded death.5–8

Diverse practices for VA field methii odology, coding and analysis have deii veloped in different centres worldwide, which means that the results are hard to compare. The International Network for the continuous Demographic Evaluii ation of Populations and Their Health (INDEPTH, http://www.indepthi network.org) is trying to standardize VA practices at DSS sites. In collaboration with this effort, we have now recoded VAs from 12 of these centres, mapping them onto the International statistical classification of diseases and related health problems, tenth revision (ICDi10) coding system, and then summarized them acii cording to the categories of the Global Burden of Disease (GBD) project.9 We then calculated ageispecific and causeispecific mortality rates. The sites included are in subiSaharan Africa and Bangladesh.

Our analysis contributes to the eviii dence base for identifying priorities for health interventions across Africa and in South Asia. It will also provide a baseline for analysis of trends in causeispecific mortality in these regions.

Methods Study population At September 2005, INDEPTH had 33 sites undertaking prospective demoii graphic surveillance of populations in developing countries across the world. All INDEPTH sites conducting VAs during 1999–2002 were invited to parii ticipate in the study, and VA data and mortality rates were assembled from 12 of these sites. The sites were Agincourt, ACDIS and Manhica in Southern Africa; Butajira, Ifakara, Kisumu and Rufiji in East Africa; Navrongo, Niakhar and Nouna in West Africa; HSIDiA and Matlab in Bangladesh.

Demographic surveillance, includii ing continuous recording of births, deaths and migrations, was done in all sites.4 For each site, the time interval for which data were analysed depended on how many data were available.

Calculating mortality rates Time at risk of disease was calculated for each individual registered in the demoii graphic surveillance system, subtracting periods of absence due to migration. Alli cause mortality rates were calculated by dividing the numbers of deaths in an age

group by the time at risk, and expressed as deaths per 1000 personiyears at risk.

We calculated causeispecific death rates for each age group by multiplying allicause mortality rate by the proportion of deaths assigned to each cause. We did not need to unambiguously assign a single cause to each death. Thus, when coders disagreed on the cause, we analysed the individual codes and used an algorithm to distribute the diagnoses across potential causes. In these instances, we allocated percentages of a death to the codes asii signed, in proportion to the number of coders who offered a diagnosis.

When the coders assigned a cause as “unknown”, we counted it as equivalent to no information. For example, if one coder assigned the cause as malaria, anii other diarrhoea, and a third unknown, the death was allocated as 50% malaria and 50% diarrhoea. When both imii mediate and underlying causes were assigned, that coder’s assignment was alii located 50:50 between the two codes, so that if the second coder in the previous example assigned the immediate cause as diarrhoea and the underlying cause as malnutrition, the death would then be divided as 50% malaria, 25% diarrhoea and 25% malnutrition.

VAs were done for most of the deaths recorded during the study, but some had too little information for the coders to assign a cause. Where the cause was indeterminate (all coders assigned it as unknown) or where no VA was done, we redistributed the deaths in proporii tion to the rates estimated from the other VAs (except for those assigned to external causes) for the same age group,

year, sex and site. We have not provided confidence

intervals for causeispecific mortality rates because this would require assumptions about the distribution of the numbers of deaths. The sample sizes for most sites are substantial, leading to narrow intervals that we have not reported in this paper.

Coding the cause of death In some sites, just one doctor assigned codes for the cause of death to VAs. In others, two doctors independently coded each VA, and a third coder reconciled disagreement. Other sites obtained codes from three independent doctors. The VA coders generally coded only one cause for each death, usually the immediate cause (i.e. the disease or complication that occurred closest to death). In some sites, the underlying cause was also coded separately. This was defined as the disease or condition that initiated the series of events leading directly to death.

Some coders used the ICDi10 coding system whereas others used loii cal systems. For this analysis, each code used locally (for either the immediate or underlying cause) was translated into a ICDi10 code. This process was checked by the investigators from the sites and reii vised as necessary. Where multiple codes were assigned for the same death, each of these codes was individually mapped onto ICDi10. The ICDi10 causes of death were then regrouped into the clasii sification used for the GBD study.9

Many sites routinely code deaths due to acute febrile illnesses as malaria, when there is no indication of any other cause. Other sites distinguish deaths

Fig. 1. All-cause mortality by age and site, in sub-Saharan Africa and Bangladesh (1999–2003)

WHO 06.05

D ea

th s

pe r

10 00

pe rs

on -y

ea rs

a t

ri sk

100

150

200

50

0

1– 40

5– 14

15 –4

4 45

–5 9

≥ 60

Age (years)

1– 40

5– 14

15 –4

4 45

–5 9

≥ 60 1– 40

5– 14

15 –4

4 45

–5 9

≥ 60 1– 40

5– 14

15 –4

4 45

–5 9

≥ 60

Agincourt

Africa Centre

Manhica

Butajira

Ifakara

Kisumu

Navrongo

Niakhar

Nouna

HSID-A

Matlab

Southern Africa East Africa West Africa Bangladesh

Rufiji

183Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Martin Adjuik et al. Measuring mortality in developing countries

due to malaria from fevers of unknown origin. To harmonize coding across sites, we grouped fevers of unknown origin under malaria for those sites with stable endemic Plasmodium falciparum transii mission, but classified such fevers under “other causes” for the remaining sites.

Age standardization Ageistandardized mortality rates were calculated for the major groups of causes, by applying ageispecific rates to the INDEPTH standard population.4 This standardization allowed comparisons between sites that accounted for their different age structures.

Results Ten of the sites are spread over subiSaharan Africa, with two sites from Bangladesh (Table 1 (web version only, available at: http://www.who.int/bulletin)). Some of these sites, notably Matlab and Navrongo, have been doing verbal autopsies for a considerable period, although data obii tained before 1999 were not analysed in this study. Other sites started verbal autopsy only during the study period of 1999–2003. The data from Butajira were derived from an initial pilot study. The size of the study populations also varied considerably, which affected the number of deaths, and thus, the number of verii bal autopsies included in the analyses. Navrongo had the largest number of VAs (8542) because of its high overall death rate, and Matlab had the second largest number (6101) because it had a large population under surveillance.

38 306 deaths were included in the analyses, of which causes were specified for 32 630 (84.9%). The percentage of deaths for which a cause could be assigned varied considerably between sites (Table 1). Excluding the data from Kisumu, where only infant and child mortality was monitored, 17.9% of deaths were in infants, 12.8% in children aged 1–4 years, and 31.8% in people older than 60 years. The percentage of deaths for which causes could be assigned was 86.8% in infants (younger than 1 year) and 83.9% in those older than 60 years.

All the sites show mortality patterns characteristic of rural populations living in poverty. The allicause mortality rates for the study period were similar to those published previously for the same sites4 with high infant mortality rates (Fig. 1), and high incidences of maternal, periii natal and infectious disease mortality

(Table 2, Table 3 and Table 4 (web verii sion only, available from http://www. who.int/bulletin)) in all sites. The most striking differences between them are in the contributions of human immunodeii ficiency virus (HIV) and malaria.

Although rates of HIV/acquired imii mune deficiency syndrome (AIDS) are

high in all African sites except Butajira and Niakhar, those in South Africa were the highest (Table 2 and Table 3), dwarfii ing even those in East Africa (Fig. 2). As expected, the age pattern of AIDS diagnosed by verbal autopsies shows clear peaks in young adults and in the youngest children; this contrasts with the

Fig. 2. Cause-specific mortality by age for communicable diseases in sub-Saharan Africa and Bangladesh (1999–2003)

Agincourt

Africa Centre

Manhica

Butajira

Ifakara

Kisumu

Navrongo

Niakhar

Nouna

HSID-A

Matlab

Southern Africa East Africa West Africa Bangladesh

Rufiji

0

D ea

th sa fr

om re

sp ir

at or

y in

fe ct

io ns

10

15

30

5

25

20

WHO 06.06

Age (years)

D ea

th sa fr

om tu

be rc

ul os

is

8

0

1– 40

5– 14

15 –4

4 45

–5 9

≥ 60 1– 40

5– 14

15 –4

4 45

–5 9

≥ 60 1– 40

5– 14

15 –4

4 45

–5 9

≥ 60 1– 40

5– 14

15 –4

4 45

–5 9

≥ 60

7 6 5 4 3 2 1

D ea

th sa fr

om di

ar rh

oe a

10

15

20

5

0

D ea

th sa fr

om H

IV /A

ID S

25

0

20

15

10

5

a Per 1000 person-years at risk.

D ea

th sa fr

om m

al ar

ia 30

40

50

20

0

10

184 Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Measuring mortality in developing countries Martin Adjuik et al.

age pattern for tuberculosis (TB), which generally showed an increase in inciii dence with age (Fig. 2).

Seven of the 12 sites have stable enii demic malaria (Table 1), which appears as the most important cause of child mortality in most of Africa, with excepii tions being the two South African sites, where it is well controlled, and Butajira in Ethiopia (Table 2). The Butajira site is an area of unstable malaria (both P. falcipp parum and P. vivax), with wide variations in transmission intensity associated with variations in altitude.

The malaria rates we have provided for stable endemic areas are inflated by the inclusion of fevers of unknown origin. In the Butajira site, there were few deaths from malaria (0.6 deaths per 1000 personiyears), malaria is seasonal and occurs in lowilying areas, and the disease could thus be excluded as a likely cause of most of the deaths from fever (pyrexia) of unknown origin (PUO). The death rate for PUO from Butajira (0.8 per 1000 personiyears, included in the category “other”) thus provides an estimate of the true rate of nonimalaria PUO mortality in the areas with stable endemic P. falciparum. This procedure suggests that there is only a small inflaii tion of the malaria mortality rates in these areas. The two South African sites, which could also be used to provide estiii mate of nonimalaria fever mortality, had negligible numbers of PUO deaths.

Incidence of death attributed to diarrhoeal diseases also varied widely, with the highest proportionate mortality in the West African sites, and the main burden in young children but with high death rates also in the elderly (Fig. 2). In most of the East and Southern African sites, diarrhoeal disease rarely causes death.

Diseases covered by WHO’s Expanded Programme on Immunization (EPI), including measles and those listed as “childhoodicluster” diseases were also most frequent in West Africa but did not often lead to death. In all sites, tropical parasitic diseases (except for malaria) colii lectively accounted for lower than 0.05 deaths per 1000 personiyears, so these conditions were not taken into account in our calculations.

Economic development is comii monly associated with a transition from infectious to noncommunicable diseases.10 Although neoplasms, diabetes and cardiovascular disease form lesser components of the overall mortality

burden in all the sites, there is evidence of health transitions in the Southern African and Bangladeshi sites, with rates for these conditions higher than elseii where in subiSaharan Africa (Fig. 3 and Fig. 4). Although Manhica is geographiii cally very close to the South African sites, its mortality patterns are more like those of the East African sites than those in South Africa, with high malaria rates, high maternal mortality, relatively low human immunodeficiency virus (HIV), and low chronic disease mortality. The southern African (including Manhica) and Bangladeshi sites, also have the highest rates of deaths due to injuries (Table 2, Fig. 3 and Fig. 4).

Sites with the highest adult mortality rates, in particular Africa Centre and Butajira, seem to have even worse mortality patterns when ageispecific

Fig. 3. Cause-specific mortality by age for noncommunicable diseases in sub-Saharan Africa and Bangladesh (1999–2003)

Agincourt

Africa Centre

Manhica

Butajira

Ifakara

Kisumu

Navrongo

Niakhar

Nouna

HSID-A

Matlab

Southern Africa East Africa West Africa Bangladesh

Rufiji

D ea

th sa fr

om nu

tr it

io na

l d ef

ic ie

nc ie

s 10

15

30

5

25

20

0

WHO 06.07

Age (years)

D ea

th sa fr

om in

ju ri

es

7

0

1– 40

5– 14

15 –4

4 45

–5 9

≥ 60 1– 40

5– 14

15 –4

4 45

–5 9

≥ 60 1– 40

5– 14

15 –4

4 45

–5 9

≥ 60 1– 40

5– 14

15 –4

4 45

–5 9

≥ 60

6 5 4 3 2 1

D ea

th sa fr

om ca

rd io

-v as

cu la

r di

se as

es 25

0

20

15

10

5

aPer 1000 person years at risk.

rates are applied to a standard population (Fig. 4). In most of the African sites, noncommunicable diseases are more important when the rates are ageistanii dardized, indicating that a major reason for the low proportions of deaths due to chronic diseases in these populations is the young average age and the low proportion of adults.

Discussion In most sites, death is mainly caused by infectious diseases, with AIDS and malaria particularly frequent, although neoii plasms, diabetes, cardiovascular disease and digestive disorders (including in the liver) are also important. There is evidence that South Africa and Bangladesh have high rates of noncommunicable diseases as well as infectious diseases.

185Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Martin Adjuik et al. Measuring mortality in developing countries

On the whole, our results are simiii lar to those of the GBD study,9,11 and WHO estimates of the causes of death in children.12 But compared with these studies, we recorded a lower contribuii tions of measles in all sites, and lower contributions of diarrhoeal diseases in most sites. Conversely, our estimates of mortality rates caused by malaria in subiSaharan African sites are higher than those suggested by the GBD study, and the AIDS rates for the South African sites also stand out as much higher than GBD or WHO estimates.

Time trends in causeispecific mortality can explain some of these differences. The WHO estimates were for 19959 for malaria and for 2001 for HIV/AIDS,11 but make use of results of epidemiological studies as far back as 1980. During this period, there have generally been an increase in overall trends in child mortality rates in subiSaharan Africa, but this probably conceals substantial reductions in death from measles as a result of the EPI proii gramme, and in diarrhoeal diseases, as result of oral rehydration therapy. Globii ally, rehydration therapy has reduced the number of children dying because of severe diarrhoea by as much as twoithirds

since it was first introduced in 1979.13 The spread of resistance to antimalarial drugs, especially chloroquine, has almost certainly led to a substantial increase in the numbers of death from malaria,14 which along with the HIV/AIDS epiii demic, has played a major part in reducii ing the overall benefits of improvements in health care.

The latest GBD estimates for subi Saharan Africa are based on a regional model that uses vital registration data from South Africa,11 but the contrast between the causes of death in Manhica and those in the nearby South African sites (all three of the southern African sites are within about 300 km of Maputo, and Manhica is nearer to Agincourt than is Africa Centre) caution against extrapoii lations of South African epidemiological data to superficially similar sites elsewhere in subiSaharan Africa with different enviii ronments, ecologies and histories.

Some of the differences between our results and those of the GBD study may also indicate different diagnostic algoii rithms and their resulting biases. The VA technique assumes that most causes of death have distinct symptom complexes that can be recognized, remembered and reported by lay respondents, and based

on this reported information, causes of deaths can be classified into useful categories. The VA method has been validated for both child 15–18 and adult mortality19,20 and results can be adjusted to allow for some of the misclassification biases21,22 However, we could assume that the same correction algorithm would be appropriate across multiple sites 23 and, in the absence of a comprehensive set of validation studies, we could not apply any general corrections for bias to our dataset.

In cases when VAs were incomii pletely linked with deaths recorded in the demographic database, we analysed all VAs available from the site. This may have led to the inclusion of a few deaths of indiii viduals who were not resident in the area, in particular in the case of the Rufiji DSS, where slightly more VAs were accrued than the number of deaths recorded.

Differences in coding between the sites meant that up to six distinct codes could be assigned for each death in some sites, leadii ing to large numbers codes being assigned, especially in Rufiji and Navrongo.

Limitations The differences between sites in perii centages of deaths for which a cause was assigned indicate both differences between sites in coding policies when the cause of death was hard to pinpoint, and also differences in the completeness of followiup. Our analysis does not disii tinguish between deaths for which there was no VA and those with a VA coded as uncertain. There are several explanations for the failure to code a death, ranging from the inability to find an individual who knew the deceased to having VA information that was extensive, but difii ficult to interpret.

Factors influencing the validity of VAs include the type of illness leading to death, characteristics of the dead person, and other factors related to the classifiii cation of causes of death, as well as the design and content of questionnaires and field procedures.7 Lack of standardizaii tion of the procedures can be a serious limitation in comparisons of VA data.24 At the time that the VAs that we report were undertaken, little progress had been made in harmonizing procedures for interviewing and coding. Subseii quent workshops within the INDEPTH network have achieved some progress, but data accrued with the standardized procedures are not yet available.

Fig. 4. Mortality by broad disease group in sub-Saharan Africa and Bangladesh (1999–2003)

25

D ea

th s

pe r

10 00

pe rs

on -y

ea rs

0

a) Unstandardized

20

15

10

5

Injuries

WHO 06.08

Southern Africa

Non-communicable Maternal, perinatal and nutritional

Infectious Other

East Africa West Africa Bangladesh

16

D ea

th s

pe r

10 00

pe rs

on -y

ea rs

0

b) Age-standardized

ButajiraManhicaAfrica Centre

Agincourt Ifakara Rufiji Navrongo Niakhar Nouna HSID-A Matlab

14 12 10 8 6 4 2

186 Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Measuring mortality in developing countries Martin Adjuik et al.

Many sites used locally designed coding systems focused on the categories of mortality most relevant to the local research agenda. We achieved a large degree of harmonization in the coding of the VAs by mapping each of these systems onto the ICDi10 codes. A broader classification makes it easier to use the same coding system in a wide range of settings,7 and though there remain discrepancies between sites in the preferii ences for different codes, most of these issues do not affect the rates when the causes are further aggregated into the GBD categories. However, much of the variation between sites in the proporii tion of deaths assigned to the category “other” results from differences in VA methodology, especially in the recordii ing of infrequent causes. The addition of codes for presumptive diagnoses to the ICD system (e.g. “acute febrile illii ness, presumed due to malaria”), would greatly facilitate standardized coding of VAs, and allow analysis of narrower categories of mortality.

The procedure of redistributing deaths of unknown cause proportionii ately to the other causes eliminates some of the inconsistencies between sites that arise from different procedures for arii riving at a consensus diagnosis from multiple coders. An alternative to our procedure is to include an additional category of indeterminate deaths, as in the WHO estimates of causes of death in children,12 an approach that recognizes that some causes (such as degenerative diseases in the elderly) are inherently harder to code than others (e.g. accidents and violence). However, in an unknown fraction of cases, the absence of etioii logical information resulted not from diagnostic problems, but rather from failure to locate relatives willing to give verbal autopsies, or from only very little information being provided. The reasons for lack of information may therefore be unrelated to the actual cause of death, thus justifying the assumption that these causes come from the same distribution as those of the other deaths.

The sites are not a random sample of areas within the countries represented, nor do they include urban areas. A thorough analysis of representativeness would involve comparison of allicause mortality rates with those estimated

from Demographic and Health Surveys, and lies outside the scope of this paper. Demographic surveillance was initiated in each site for different reasons, but in each case to provide epidemiological information for the wider social and ecological zone in which it is found. Some of the differences between sites clearly reflect differences in procedures, for example the high proportion of unclassifiable deaths in Agincourt was probably a result of the local operatii ing procedures used by the coders. Child malnutrition, which is related to many deaths attributed to other causes, contributed to many deaths in Kisumu, but this high frequency could also reflect local coding preferences for multicausal deaths. A comparison of nutritional indices between sites would help to indicate whether there are real epidemiological differences. Other differences, such as the high rates of neonatal mortality in Kisumu, are difii ficult to explain other than as a true epidemiological occurrence.

Malaria In areas of stable endemic malaria (in seven sites), coders assumed that deaths associated with acute febrile illness were due to malaria, unless there was strong evidence for an alternative cause. For consistency, we allocated deaths assigned to fevers of unknown origin as being caused by malaria in all sites with endemic P. falciparum. Although this process might seem likely to exagii gerate the effect of malaria, assignment of malaria deaths by verbal autopsy has a sensitivity less than 100%, as well as imperfect specificity.16,18,22 Since death from fever of unknown origin in both Butajira and South Africa is infrequent, it is unlikely that our assumption inii troduced any significant bias into child mortality rates. It seems likely though that many, if not most, deaths in the over 45iyear age group coded as malaria were caused by other febrile illnesses. P. falciparum malaria is overidiagnosed in adults in endemic areas.25,26

HIV/AIDS HIVirelated deaths are often associated with TB, which introduces a further eleii ment of uncertainty about the cause of death. In Matlab, HIV prevalence is low

and TB was recognized as a major cause of death before the HIV epidemic.27 In such situations, it is unlikely that many TB deaths were related to underlying HIV infection. But in the Africa Centre, HIV testing is integrated into local reii search programmes, meaning that HIV status could be determined. In most of the other African sites, the proportion of the TB deaths with underlying HIV remains unclear. However, the different age trends for AIDS and TB mortality show that VA coders do distinguish these etiologies even in areas of high endemicii ity of both infections.

Many deaths are clearly mulii tifactorial, and can involve several medical conditions. Some factors such as underinutrition are recognized as important underlying causes of many deaths associated with infectious diseases 28 but are likely to appear in VAs in only the most clearicut cases. Other forms of coimorbidity are underireii searched but may well be involved in many deaths. The effect of such causes is better measured by prospecii tive studies of the overall impact of the risk factor on allicause mortalii ity.29,30 Data on the cause of death thus has a role in the assessment of the numbers of deaths that can be averted by specific interventions, such as antii smoking campaigns 31 or integrated management of childhood infections (IMCI),32 but we caution against inferii ring mortality amenable to health care directly from causeispecific rates.

Our estimates of causeispecific mortality rates should influence reii source allocation within international health agencies. They should also prove a valuable contribution to the evidence base for identifying health intervention priorities across Africa and in South Asia. Our results will also form a baseline for analysis of trends in causeispecific mortality over time, both in the context of interventions within the INDEPTH sites and across the regions represented by these centres. Demographic surveilii lance and verbal autopsy programmes continue in these sites and will in future provide further data, directly comparable with this baseline, with which to evaluate trends in cause specific mortality. O

Competing interests: none declared.

187Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Martin Adjuik et al. Measuring mortality in developing countries

Résumé

Taux de mortalité par cause en Afrique subsaharienne et au Bangladesh Objectif Fournir des données comparables au niveau international sur la fréquence des différentes causes de décès. Méthodes Il s’agissait d’analyser les autopsies verbales transmises entre 1999 et 2002 par 12 sites de surveillance démographique en Afrique subsaharienne et au Bangladesh afin de déterminer les taux de mortalité par cause et par âge. Les codes affectés aux causes de mortalité utilisés par les sites ont été harmonisés pour être conformes au système de la CIM10 et récapitulés selon le système de catégorisation de la charge de morbidité mondiale 2000 (version 2). Résultats Les causes de décès dans les sites africains sont très différentes de celles relevées au Bangladesh, où certains éléments indiquent une évolution de la morbidité des maladies transmissibles

aux maladies non transmissibles et où le paludisme est peu présent. Le VIH est en revanche la cause dominante de mortalité dans les sites sud-africains à la différence de ce que l’on observe dans les sites à forte endémie palustre des autres pays d’Afrique subsaharienne (même au Mozambique voisin). Les contributions à la mortalité de la rougeole et des maladies diarrhéiques sont moins élevées en Afrique subsaharienne qu’on ne le pensait précédemment, alors que le paludisme revêt une importance relativement plus grande. Conclusion Les différents schémas de mortalité mis en évidence résultent peut-être d’une modification récente de la disponibilité et de l’efficacité des interventions sanitaires contre les maladies de l’enfant apparaissant en grappes.

Resumen

Tasas de mortalidad por causas específicas en el África subsahariana y en Bangladesh Objetivo Aportar datos comparables internacionalmente sobre la frecuencia de las distintas causas de defunción. Métodos Analizamos las autopsias verbales obtenidas durante 1999–2002 en 12 sitios de vigilancia demográfica del África subsahariana y de Bangladesh a fin de determinar las tasas de mortalidad por causas y por edades. Los códigos de las causas de defunción utilizados por los distintos sitios fueron armonizados con arreglo al sistema de la CIE-10, y resumidos mediante el sistema de clasificación de la Carga Mundial de Morbilidad 2000 (versión 2). Resultados Las causas de defunción en África difieren marcadamente de las observadas en Bangladesh, donde los datos sugieren una transición sanitaria hacia las enfermedades no transmisibles, con pocos casos de malaria. La infección por

VIH destaca entre las causas de mortalidad en los lugares de Sudáfrica analizados, que contrastan con las causas observadas en los lugares de alta endemicidad de malaria del resto del África subsahariana (incluso en el vecino Mozambique). La contribución del sarampión y de las enfermedades diarreicas a la mortalidad en el África subsahariana es inferior a la sugerida hasta ahora, mientras que la malaria tiene una importancia relativamente mayor. Conclusión Los diferentes perfiles de mortalidad que hemos observado podrían ser el resultado de los últimos cambios experimentados por la disponibilidad y la eficacia de las intervenciones sanitarias contra las enfermedades infecciosas infantiles más comunes.

Arabic

188 Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Measuring mortality in developing countries Martin Adjuik et al.

1. Ruzicka LT, Lopez AD. The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q 1990;43:249-58.

2. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ 2005;83:171-7.

3. Lopez AD. Causes of death: an assessment of global patterns of mortality around 1985. World Health Stat Q 1990;43:91-104.

4. INDEPTH Network. Population, Health and Survival at INDEPTH Sites. Ottowa: IDRC; 2002.

5. Reeves BC, Quigley M. A review of data-derived methods for assigning causes of death from verbal autopsy data. Int J Epidemiol 1997;26:1080-9.

6. Ronsmans C, Vanneste AM, Chakraborty J, Van Ginneken J. A comparison of three verbal autopsy methods to ascertain levels and causes of maternal deaths in Matlab, Bangladesh. Int J Epidemiol 1998;27:660-6.

7. Chandramohan D, Maude GH, Rodrigues LC, Hayes RJ. Verbal autopsies for adult deaths: issues in their development and validation. Int J Epidemiol 1994;23:213-22.

8. Lulu K, Berhane Y. The use of simplified verbal autopsy in identifying causes of adult death in a predominantly rural population in Ethiopia. BMC Public Health 2005;5:58.

9. Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard (MA): Harvard University Press; 1996.

10. Heuveline P, Guillet M, Gwatkin DK. The uneven tides of the health transition. Soc Sci Med 2002;55:313-22.

11. Mathers CD, Stein CM, Fat DM, Rao C, Inoue M, Tomijima N, et al. Global Burden of Disease 2000: Version 2 methods and results, Global Programme on Evidence for Health Policy Discussion Paper No. 50. Geneva: World Health Organization; 2002.

12. Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet 2005;365:1147-52.

13. Victora CG, Bryce J, Fontaine O, Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ 2000;78:1246-55.

14. Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 2001;64 Suppl 1-2:12-7.

15. Kalter HD, Gray RH, Black RE, Gultiano SA. Validation of postmortem interviews to ascertain selected causes of death in children. Int J Epidemiol 1990;19:380-6.

16. Snow R, Armstrong-Schellenberg JR, Forster D, Winstanley MT, Marsh VM, Newton C, et al. Childhood deaths in Africa: uses and limitations of verbal autopsies. Lancet 1992;340:351-5.

17. Maude GH, Ross DA. The effect of different sensitivity, specificity and cause-specific mortality fractions on the estimation of differences in cause- specific mortality rates in children from studies using verbal autopsies. Int J Epidemiol 1997;26:1097-106.

18. Quigley MA, Armstrong-Schellenberg JR, Snow R. Algorithms for verbal autopsies: a validation study in Kenyan children. Bull World Health Organ 1996;74:147-54.

19. Quigley MA, Chandramohan D, Rodrigues LC. Diagnostic accuracy of physician review, expert algorithms and data-derived algorithms in adult verbal autopsies. Int J Epidemiol 1999;28:1081-7.

20. Quigley MA, Chandramohan D, Setel P, Binka F, Rodrigues LC. Validity of data-derived algorithms for ascertaining causes of adult death in two African sites using verbal autopsy. Trop Med Int Health 2000;5:33-9.

21. Anker M. The effect of misclassification error on reported cause-specific mortality fractions from verbal autopsy. Int J Epidemiol 1997;26:1090-6.

22. Korenromp EL, Williams BG, Gouws E, Dye C, Snow R. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis 2003;3:349-58.

23. Chandramohan D, Setel P, Quigley M. Effect of misclassification of causes of death in verbal autopsy: can it be adjusted? Int J Epidemiol 2001;30:509-14.

24. Bang AT, Bang RA. Diagnosis of causes of childhood deaths in developing countries by verbal autopsy: suggested criteria. The SEARCH Team. Bull World Health Organ 1992;70:499-507.

25. Makani J, Matuja W, Liyombo E, Snow R, Marsh K, Warrell DA. Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description. QJM 2003;96:355-62.

26. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004;329:1212.

27. International Center for Diarrheal Disease Research, Bangladesh. ICDDR,B’s programme to address emerging and re-emerging infectious diseases. Glimpse 1998;20:6-7.

28. Caulfield LE, de Onis M, Blossner M, Black RE. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr 2004;80:193-8.

29. Ezzati M, Vander Hoorn S, Rodgers A, Lopez A, Mathers C, Murray C, et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003;362:271-80.

30. Rodgers A, Ezzati M, Van der Hoorn S, Lopez AD, Lin RB, Murray CJ. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med 2004;1:e27.

31. Nolte E, McKee M. Measuring the health of nations: analysis of mortality amenable to health care. BMJ 2003;327:1-5.

32. Armstrong-Schellenberg JR, Adam T, Mshinda H, Masanja H, Kabadi G, Mukasa O, et al. Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in Tanzania. Lancet 2004;364: 1583-94.

References

�Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Martin �djuik et al. Measuring mortality in developing countries

Table 1. Details of verbal autopsies undertaken and death rates measured at 12 study sites across sub-Saharan �frica and Bangladesh

Site Period of Deaths during Person-years Crude death Verbal Verbal autopsies Deaths with Total number Endemic analysis surveillance at risk rate (per 1000 autopsies with a cause unknown of codes malaria person-years) analysed of deatha cause (%) analysed

Agincourt (South Africa) 1999–2003 2963 342 906 8.6 2756 1887 36.3 1 887 No ACDIS (South Africa) 2000–2003 4270 259 216 16.5 4215 4095 4.1 4 095 No Manhica (Mozambique) 2001–2003 2940 147 774 19.9 1252 1251 57.4 3 502 Yes Butajira (Ethiopia) 2000 305 25 624 11.9 211 203 33.4 279 No Ifakara (United Republic of Tanzania) 2000–2002 2774 242 605 11.4 1893 1844 33.5 4 620 Yes Kisumu (Kenya) 2002 1048 15 568 NAb 1048 1046 0.2 1 046 Yes Rufiji (United Republic of Tanzania) 1999–2002 3989 323 934 12.3 4078 3938 1.3 12 477 Yes Navrongo (Ghana) 1999–2002 8730 560 190 15.6 8542 8484 2.8 27 555 Yes Niakhar (Senegal) 1999–2002 1808 123 314 14.7 1343 1335 26.2 1 335 Yes Nouna (Burkina Faso) 1999–2002 2655 214 165 12.4 2191 2102 20.8 5 011 Yes HSID (Bangladesh) 1999–2002 723 120 668 6.0 723 694 4.0 697 No Matlab (Bangladesh) 1999–2002 6101 878 700 6.9 6101 5751 5.7 5 778 No

a Excluding those verbal autopsies where the only code was uncertain. b Kisumu had data for only a subset of the age-groups so death rate could not be calculated.

B Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Measuring mortality in developing countries Martin �djuik et al.

Table 2. Cause-specific mortality rates for all age-groups at 12 study sites across sub-Saharan �frica and Bangladesh

Deaths (%) Deaths per 1000 person-years at risk

Cause of death �gincourt �CDIS Manhica Butajira Ifakara Rufiji Navrongo Niakhar Nouna HSID-� Matlab �gincourt �CDIS Manhica Butajira Ifakara Rufiji Navrongo Niakhar Nouna HSID-� Matlab

Tuberculosis 9.0 4.1 10.1 12.8 3.9 2.6 2.4 1.3 1.1 1.6 2.8 0.8 0.7 2.0 1.5 0.4 0.3 0.4 0.2 0.1 0.1 0.2

HIV/AIDS 32.4 51.3 9.5 0.0 6.3 8.7 2.1 0.0 7.3 0.0 0.0 2.8 8.2 1.9 0.0 0.7 1.1 0.3 0.0 0.9 0.0 0.0

Diarrhoeal 4.0 1.8 7.2 10.2 3.8 3.7 11.3 21.8 13.6 2.7 4.2 0.3 0.3 1.4 1.2 0.4 0.5 1.8 3.2 1.7 0.2 0.3 diseases

Childhood cluster 0.1 0.1 0.2 1.2 0.4 0.5 0.3 1.2 1.5 1.3 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.1 0.0 diseases

Meningitis 0.7 1.7 1.9 3.7 1.3 0.2 2.6 6.7 2.3 0.0 0.1 0.1 0.3 0.4 0.4 0.2 0.0 0.4 1.0 0.3 0.0 0.0

Hepatitis 0.2 0.3 0.0 1.5 0.4 0.2 0.4 0.2 0.5 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0

Malariaa 2.8 0.7 20.5 5.4 29.8 29.2 19.0 34.5 35.3 0.0 0.0 0.2 0.1 4.1 0.6 3.4 3.6 3.0 5.1 4.4 0.0 0.0

Other infectious 1.0 0.9 1.7 1.0 6.0 4.9 8.9 4.2 0.2 1.4 0.4 0.1 0.1 0.3 0.1 0.7 0.6 1.4 0.6 0.0 0.1 0.0 diseases

Respiratory infections 3.8 5.6 7.5 14.8 9.2 9.3 9.4 8.5 12.1 5.0 5.8 0.3 0.9 1.5 1.8 1.1 1.1 1.5 1.2 1.5 0.3 0.4

Maternal conditionsb 0.5 0.4 0.8 1.0 1.6 1.3 0.8 1.5 1.4 0.6 0.8 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.2 0.0 0.1

Conditions arising in 2.0 1.6 2.9 13.2 12.4 6.4 2.4 8.6 2.6 10.2 10.5 0.2 0.3 0.6 1.6 1.4 0.8 0.4 1.3 0.3 0.6 0.7 the perinatal periodb

Nutritional deficiencies 2.7 0.7 1.7 5.8 2.0 6.7 3.4 0.9 1.6 1.4 6.2 0.2 0.1 0.3 0.7 0.2 0.8 0.5 0.1 0.2 0.1 0.4

Malignant neoplasms 7.5 3.7 2.9 2.0 1.5 1.0 1.2 1.4 1.3 5.8 4.1 0.7 0.6 0.6 0.2 0.2 0.1 0.2 0.2 0.2 0.4 0.3

Non-malignant 0.0 0.1 0.0 0.0 1.0 0.8 0.4 0.0 0.1 1.9 2.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 neoplasms

Diabetes 1.7 1.6 0.3 0.5 0.3 0.7 0.1 0.3 0.1 2.7 1.6 0.2 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1

Endocrine disorders 0.1 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Neuro-psychiatric 1.5 0.6 1.3 1.9 1.4 1.1 0.9 1.2 0.7 4.2 0.5 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.3 0.0 conditions

Cardiovascular 10.6 10.2 7.2 4.9 5.1 4.7 6.5 1.4 5.4 17.0 13.4 0.9 1.6 1.4 0.6 0.6 0.6 1.0 0.2 0.7 1.0 0.9 diseases

Respiratory diseases 1.1 0.9 0.6 0.3 1.0 1.3 0.2 0.7 0.4 7.1 8.0 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.4 0.6

Digestive diseases 3.2 1.3 2.5 3.7 1.4 0.4 0.8 2.1 2.7 3.9 4.6 0.3 0.2 0.5 0.4 0.2 0.1 0.1 0.3 0.3 0.2 0.3

Genito-urinary 1.4 1.0 1.2 3.2 1.3 0.9 2.1 0.8 0.9 1.3 1.0 0.1 0.2 0.2 0.4 0.1 0.1 0.3 0.1 0.1 0.1 0.1 diseases

Skin diseases 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1

Congenital anomalies 0.5 0.5 0.5 1.2 0.3 0.7 0.0 0.2 0.2 0.3 0.3 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0

Injuries 12.6 9.5 9.0 3.8 4.1 2.4 4.9 1.7 4.6 14.0 8.7 1.1 1.5 1.8 0.5 0.5 0.3 0.8 0.2 0.6 0.8 0.6

Other 0.1 1.6 5.8 8.0 5.7 12.4 20.0 1.1 3.9 17.3 23.3 0.0 0.3 1.2 1.0 0.6 1.5 3.1 0.2 0.5 1.0 1.6

a Including, for those sites with stable endemic malaria only, febrile illness of unknown origin; data from Kisumu were only available for children, and are therefore not included here. b Although perinatal mortality is usually expressed as deaths per 1000 live-births, and maternal mortality as deaths per 1000 live-births, the rates are based on the total person-years for all ages as a denominator to maintain consistency with the other causes.

CBulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Martin �djuik et al. Measuring mortality in developing countries

Table 3. Cause-specific mortality in children younger than 5 years in 12 study sites across sub-Saharan �frica and Bangladesh

Percentage of deaths Deaths per 1000 person-years at risk

Cause of �gincourt �CDIS Manhica Butajira Ifakara Kisumu Rufiji Navrongo Niakhar Nouna HSID-� Matlab �gincourt �CDIS Manhica Butajira Ifakara Kisumu Rufiji Navrongo Niakhar Nouna HSID-� Matlab death

Tuberculosis 2.4 0.8 0.8 7.4 0.9 1.3 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.3 1.8 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 HIV/AIDS 34.2 42.5 6.5 0.0 1.0 1.1 1.4 0.0 0.0 2.8 0.0 0.0 4.5 8.7 2.5 0.0 0.3 0.7 0.4 0.0 0.0 0.9 0.0 0.0 Diarrhoeal 14.7 4.4 9.0 11.1 2.8 5.7 3.3 13.3 27.9 14.9 4.0 5.2 1.9 0.9 3.5 2.7 0.8 3.9 0.9 4.5 12.5 4.6 0.5 0.8 diseases Childhood 0.0 0.0 0.7 2.0 0.9 0.4 1.0 0.6 1.3 2.9 5.9 0.3 0.0 0.0 0.3 0.5 0.3 0.3 0.3 0.2 0.6 0.9 0.7 0.1 cluster diseases Meningitis 0.5 1.7 4.8 6.4 1.2 3.0 0.1 3.1 3.7 2.7 0.0 0.3 0.1 0.3 1.8 1.6 0.3 2.0 0.0 1.0 1.6 0.8 0.0 0.1 Hepatitis 0.3 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 Malariaa 0.3 0.2 28.9 0.0 40.3 22.4 38.2 32.2 35.9 51.2 0.0 0.0 0.0 0.0 11.1 0.0 11.8 15.1 9.8 11.0 16.0 15.8 0.0 0.0 Other infectious 3.4 2.3 3.5 1.5 3.5 0.0 5.3 7.9 4.4 0.2 0.7 0.7 0.5 0.5 1.4 0.4 1.0 0.0 1.4 2.7 2.0 0.1 0.1 0.1 diseases Respiratory 13.2 26.1 13.1 20.8 11.7 14.4 16.0 13.9 9.6 9.8 20.4 15.9 1.7 5.3 5.0 5.1 3.4 9.7 4.1 4.8 4.3 3.0 2.5 2.4 infections Conditions 10.0 10.1 11.6 23.4 28.0 18.7 17.6 8.6 12.4 5.5 46.7 40.0 1.3 2.1 4.5 5.8 8.3 12.6 4.5 3.0 5.5 1.7 5.7 6.0 arising in the perinatal periodb

Nutritional 13.2 4.0 5.7 10.1 3.1 21.3 11.3 9.1 1.0 2.7 3.3 13.1 1.7 0.8 2.2 2.5 0.9 14.4 2.9 3.1 0.4 0.8 0.4 2.0 deficiencies Malignant 0.3 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 neoplasms Non-malignant 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 neoplasms Diabetes 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Endocrine 0.0 0.0 6.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 disorders Neuro-psychiatric 1.1 0.0 0.9 1.0 0.2 0.2 0.3 0.0 0.7 0.0 0.7 0.0 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 conditions Cardiovascular 0.0 0.0 0.0 1.0 0.2 0.2 0.2 0.0 0.3 0.1 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 diseases Respiratory 0.5 0.2 0.3 0.0 0.3 0.0 0.2 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 diseases Digestive diseases 0.5 0.2 0.6 2.9 0.0 0.1 0.1 0.0 0.1 0.7 0.0 0.9 0.1 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 Genito-urinary 0.0 0.2 0.8 0.0 0.5 0.0 0.3 0.0 0.8 0.8 1.3 0.4 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.2 0.2 0.1 diseases Skin diseases 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 Congenital 2.1 2.6 1.8 2.5 0.6 0.0 2.0 0.0 0.2 0.5 1.3 1.1 0.3 0.5 0.7 0.6 0.2 0.0 0.5 0.0 0.1 0.2 0.2 0.2 anomalies Injuries 3.4 3.5 3.5 2.3 2.8 0.7 0.7 3.4 0.3 2.1 9.2 15.8 0.5 0.7 1.3 0.6 0.8 0.5 0.2 1.2 0.1 0.7 1.1 2.4

Other 0.0 0.9 1.4 7.8 1.9 9.8 1.5 7.9 1.0 2.2 4.6 4.3 0.0 0.1 0.4 1.8 0.6 6.6 0.4 2.7 0.4 0.6 0.6 0.6

a Including, for those sites with stable endemic malaria only, febrile illness of unknown origin; data from Kisumu were only available for children, and are therefore not included here. b Although perinatal mortality is usually expressed as deaths per 1000 live-births, and maternal mortality as deaths per 1000 live-births, the rates are based on the total person-years for all ages as a denominator to maintain consistency with the other causes.

D Bulletin of the World Health Organization | March 2006, 84 (3)

Special Theme – Estimating Mortality Measuring mortality in developing countries Martin �djuik et al.

Table 4. Cause specific mortality in people aged 15 years or older in 12 study sites across sub-Saharan �frica and Bangladesh

Percentage of deaths Deaths per 1000 person-years at risk

Cause of death �gincot �CDIS Manhica Butajia Ifakara Rufiji Navrongo Niakhar Nouna HSID-� Matlab �gincourt �CDIS Manhica Butajira Ifakara Rufiji Navrongo Niakhar Nouna HSID-� Matlab

Tuberculosis 11.0 4.9 14.1 18.6 6.7 4.0 3.6 6.4 2.3 2.1 3.9 1.2 1.0 3.0 2.3 0.7 0.5 0.6 0.7 0.3 0.1 0.3

HIV/AIDS 32.6 53.7 11.0 0.0 11.6 13.5 3.2 0.0 12.3 0.0 0.0 3.6 11.4 2.4 0.0 1.3 1.8 0.6 0.0 1.4 0.0 0.0

Diarrhoeal diseases 1.2 1.3 6.7 8.5 4.7 4.0 10.6 8.1 12.6 2.4 3.7 0.1 0.3 1.4 1.0 0.5 0.5 1.8 0.9 1.4 0.2 0.3

Childhood cluster 0.1 0.0 0.0 0.6 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 diseases

Meningitis 0.5 1.4 0.7 1.1 1.2 0.2 1.7 3.4 1.3 0.0 0.0 0.1 0.3 0.2 0.1 0.1 0.0 0.3 0.4 0.2 0.0 0.0

Hepatitis 0.2 0.3 0.0 3.4 0.7 0.1 0.5 0.4 0.5 0.2 0.6 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0

Malariaa 3.2 0.7 16.7 9.0 18.2 22.6 13.5 23.9 19.7 0.0 0.0 0.4 0.2 3.6 1.1 2.0 3.1 2.3 2.5 2.2 0.0 0.0

Other infectious 0.3 0.6 1.0 0.6 8.6 4.6 9.6 2.6 0.2 1.7 0.2 0.0 0.1 0.2 0.1 0.9 0.6 1.7 0.3 0.0 0.1 0.0 diseases

Respiratory infections 1.5 1.7 5.5 9.0 7.4 5.7 7.7 9.0 15.5 0.7 2.2 0.2 0.4 1.2 1.1 0.8 0.8 1.3 0.9 1.7 0.0 0.2

Maternal conditionsb 0.6 0.5 1.1 2.3 1.5 2.1 1.1 8.6 2.9 0.8 1.0 0.1 0.1 0.2 0.3 0.2 0.3 0.2 0.9 0.3 0.1 0.1

Conditions arising in 0.0 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 the perinatal periodb

Nutritional deficiencies 0.0 0.0 0.2 0.0 1.0 3.7 0.7 0.4 0.5 0.9 3.6 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.3

Malignant neoplasms 9.7 4.3 4.3 4.5 2.6 1.3 1.8 7.3 2.7 7.6 5.5 1.1 0.9 0.9 0.6 0.3 0.2 0.3 0.8 0.3 0.5 0.4

Other neoplasms 0.0 0.0 0.0 0.0 2.0 1.4 0.6 0.0 0.1 2.1 3.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.2

Diabetes 2.2 2.0 0.5 1.1 0.6 1.2 0.1 1.3 0.2 3.6 2.3 0.2 0.4 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.2

Endocrine disorders 0.1 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Neuro-psychiatric 1.4 0.6 1.5 3.2 2.5 1.5 1.3 2.1 1.2 5.3 0.6 0.2 0.1 0.3 0.4 0.3 0.2 0.2 0.2 0.1 0.4 0.1 conditions

Cardiovascular 13.7 12.5 10.3 10.2 10.1 7.8 9.8 5.1 11.3 22.1 18.8 1.5 2.7 2.2 1.2 1.1 1.1 1.7 0.5 1.2 1.5 1.5 diseases

Respiratory diseases 1.2 1.0 0.7 0.6 1.6 2.0 0.3 1.7 0.7 9.3 11.0 0.1 0.2 0.1 0.1 0.2 0.3 0.0 0.2 0.1 0.6 0.9

Digestive diseases 3.9 1.5 3.2 5.1 2.7 0.7 1.2 10.7 4.7 4.9 6.0 0.4 0.3 0.7 0.6 0.3 0.1 0.2 1.1 0.5 0.3 0.5

Genito-urinary 1.9 1.2 1.3 7.3 1.9 1.2 3.2 0.4 0.7 1.3 1.1 0.2 0.3 0.3 0.9 0.2 0.2 0.6 0.0 0.1 0.1 0.1 diseases

Skin diseases 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.2 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1

Congenital anomalies 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Injuries 13.7 10.2 10.9 4.9 5.1 3.0 4.8 6.0 5.8 14.4 5.2 1.5 2.2 2.3 0.6 0.6 0.4 0.8 0.6 0.6 1.0 0.4

Other 0.1 1.6 6.2 7.3 9.4 19.2 24.8 1.3 4.1 20.6 30.5 0.0 0.3 1.3 0.9 1.0 2.6 4.3 0.1 0.5 1.4 2.4

a Including, for those sites with stable endemic malaria only, febrile illness of unknown origin; data from Kisumu were only available for children, and are therefore not included here. b Although perinatal mortality is usually expressed as deaths per 1000 live-births, and maternal mortality as deaths per 1000 live-births, the rates are based on the total person-years for all ages as a denominator to maintain consistency with the other causes.

Основные сведения
Тип документа Journal articles
Дата принятия
Источник Всемирная организация здравоохранения